Humana Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- James A. Rechtin
- Full Time Employees
- 65,680
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- Address
- Humana Building Louisville KY United States of America 40202
- IPO Date
- Dec 31, 1981
- CIK
- 0000049071
- Website
- humana.com
- Similar Companies
- Business
- Humana Inc. is a leading health insurance company providing medical and specialty insurance products and healthcare services primarily in the United States. Founded in 1961 and headquartered in Louisville, Kentucky, the company operates through two main segments, Insurance and CenterWell; the Insurance segment offers Medicare Advantage plans, Medicaid benefits, dual eligible and long-term support services, commercial fully-insured medical and specialty health insurance including dental and vision benefits, administrative services only products, and military services such as the TRICARE East Region contract, while CenterWell encompasses pharmacy benefit management, retail pharmacies, senior-focused primary care centers, and home solutions including home health and hospice services to health plan members and third parties. Products are sold through employers, employees, independent brokers and agents, sales representatives, and digital insurance agencies, serving nearly 20 million members across all 50 states with a focus on individuals aged 65 and older, employer groups, and military personnel. Recent strategic developments include the launch of a Medicaid contract in Virginia in July 2025, expanding Humana's active state footprint to 10 with pending awards in Georgia, Texas, and Michigan; the acquisition of Florida provider The Villages Health for $50 million in July 2025 to bolster CenterWell's primary care capabilities; strong growth in CenterWell adding 56,600 patients in Q3 2025 alongside expansion of its specialty pharmacy business; and a leadership transition with James Rechtin as CEO and affirmed full-year 2025 financial guidance amid Medicare Advantage adjustments.
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?
The Humana Foundation Deepens Investment in Emotional Health, Announcing Over $12 Million in New Grants
Dario Appoints Former Humana Chief Compliance Officer Sean O'Reilly to Advisory Board to Support Strategic Growth and Healthcare Partnerships
How CenterWell Is Driving Humana's Growth Beyond Insurance
Swedish care provider Ambea makes recommended $304 million offer for Humana
Can Humana's Margin Recovery Drive Long-Term Earnings Growth?
Humana Inc. (NYSE: HUM) Investor Alert: Schubert Jonckheer Investigating Possible False Statements Regarding Healthcare Utilization Costs, Over $104 Million Insider Sales
Humana Inc. (NYSE: HUM) Investor Alert: Schubert Jonckheer Investigating Possible False Statements Regarding Healthcare Utilization Costs, Over $104 Million Insider Sales
Humana Inc. to Release Second Quarter 2026 Results on July 29, 2026
UnitedHealth vs. Humana: Which Healthcare Leader Is a Better Bet Now?
3 Stocks Doing the Heavy Lifting in Healthcare's Rebound
The Big 3: HUM, BAC, MSFT
The Healthcare M&A Wave
Humana Awarded Statewide Illinois HealthChoice Medicaid Contract, Expanding Access to Care Across the State
Humana, CenterWell and National Hispanic Medical Association Announce 2026 Resident Physician Scholarship Program Recipients
Invesco's RSPH vs. PJP: Which Health Care ETF Is the Better Fund For The GLP-1 Revolution?
Humana Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humana Inc. - HUM
First Look: SpaceX Launches Largest-Ever IPO; Oracle Tumbles, ECB Hikes Rates
Humana Closes the Kindred Chapter With $900 Million Gentiva Exit